Orange Book product · Brand (NDA)
FORFIVO XL
BUPROPION HYDROCHLORIDE
At a glance
Nov 10, 2011
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 10, 2011
14 yr 10 mo ago
Today
Patent 7674479 expires
Listed drug product patent expiration.
Aug 23, 2028
in 2 yr 3 mo
Pharmaceutical detail
Active ingredient
BUPROPION HYDROCHLORIDE
Strength
450MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 022497
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2026BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 220529 · YICHANG HUMANWELL
- 2025BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 217898 · ANNORA PHARMA
- 2025BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 207874 · IPCA LABS LTD
- 2024BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 218385 · GRANULES
- 2023BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 216800 · ANNORA PHARMA
- 2023BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 216766 · YICHANG HUMANWELL
- 2022BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 215568 · GRANULES
- 2020BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 203650 · SUN PHARM
- 2020BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 200216 · SUN PHARM
- 2019BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 211020 · GRAVITI PHARMS
- 2018BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 210497 · ACCORD HLTHCARE
- 2018BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 211347 · YICHANG HUMANWELL
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7674479 | Aug 23, 2028 | in 2 yr 3 mo | Product |

